Fig. 7From: MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancermiR-585-3p targeted CAPN9. A Binding site locations (positions 86–93) were listed. B miR-585-3p mimics and a plasmid containing either a wild-type or mutated 3’-UTR sequences of CAPN9 were transferred into SKOV3 cells. C MTT assay was performed. *P < 0.05. D The amount of CAPN9 protein was determined via western blot. E The western blot was carried out to test the CAPN9 protein levels following transfectionBack to article page